Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gabapentin does not affect antipyrine clearance.

E Allen1, L M Tsanaclis, S J Wroe

  • 1Guy's Drug Research Unit, London, United Kingdom.

Journal of Clinical Pharmacology
|September 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartphone-based hyperspectral imaging for ice sheet and proglacial applications in South-West Greenland.

The Science of the total environment·2024
Same author

Is being a victim of bullying or cyberbullying in secondary school associated with subsequent risk-taking behavior in adolescence? A longitudinal study in secondary schools.

Journal of adolescence·2022
Same author

Feasibility and acceptability of a whole-school social-marketing intervention to prevent unintended teenage pregnancies and promote sexual health: evidence for progression from a pilot to a phase III randomised trial in English secondary schools.

Pilot and feasibility studies·2022
Same author

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients.

Arthritis care & research·2017
Same author

Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa.

Clinical pharmacology and therapeutics·2017
Same author

Impact of baseline vitamin B12 status on the effect of vitamin B12 supplementation on neurologic function in older people: secondary analysis of data from the OPEN randomised controlled trial.

European journal of clinical nutrition·2017

Gabapentin, an anti-seizure medication, did not alter antipyrine clearance in healthy volunteers. Unlike phenytoin, gabapentin showed minimal potential for drug interactions, suggesting it is safe for co-administration.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Clinical Pharmacology

Background:

  • Drug interactions can significantly alter therapeutic efficacy and safety.
  • Understanding the metabolic pathways of commonly prescribed drugs is crucial.
  • Gabapentin is widely used for epilepsy and neuropathic pain.

Purpose of the Study:

  • To evaluate the effect of gabapentin on the metabolic clearance of antipyrine.
  • To compare gabapentin's interaction potential with that of phenytoin, a known enzyme inducer.

Main Methods:

  • A randomized controlled study involving 12 healthy male volunteers.
  • Administration of gabapentin (400 mg TID) or phenytoin (100 mg TID) for 2 weeks.
  • Antipyrine tests conducted pre-treatment, during, and post-treatment.

Related Experiment Videos

Main Results:

  • Chronic gabapentin administration did not significantly affect antipyrine clearance.
  • Phenytoin administration resulted in altered antipyrine clearance, as expected for an enzyme inducer.
  • Gabapentin demonstrated a lack of significant impact on the tested drug-metabolizing pathway.

Conclusions:

  • Gabapentin exhibits a low potential for clinically significant drug interactions related to cytochrome P450 enzyme activity.
  • These findings support the favorable safety profile of gabapentin regarding drug-drug interactions.
  • Further research may explore interactions with other drug classes or metabolic pathways.